Transferrin-Conjugated Polymeric Nanoparticle for Receptor-Mediated Delivery of Doxorubicin in Doxorubicin-Resistant Breast Cancer Cells

In this study, a transferrin (T(f))-conjugated polymeric nanoparticle was developed for the targeted delivery of the chemotherapeutic agent doxorubicin (Dox) in order to overcome multi-drug resistance in cancer treatment. Our objective was to improve Dox delivery for producing significant antitumor...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pharmaceutics
Autors principals: Soe, Zar Chi, Kwon, Jun Bum, Thapa, Raj Kumar, Ou, Wenquan, Nguyen, Hanh Thuy, Gautam, Milan, Oh, Kyung Taek, Choi, Han-Gon, Ku, Sae Kwang, Yong, Chul Soon, Kim, Jong Oh
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6410246/
https://ncbi.nlm.nih.gov/pubmed/30717256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics11020063
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars